BUZZ BOMB™ captures over 400,000 views and a spike in online revenue driven by strategic brand expansion and Ashley ...
Study represents a significant advancement in Grove’s Bionic Biologics™ platform – CHICAGO--(BUSINESS WIRE)--February 24, 2026-- Grove Biopharma, ...
Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today ...
ESTERO, FLORIDA / ACCESS Newswire / February 11, 2026 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the ...
Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company") today announced that its wholly owned subsidiary ...
New delivery system targets rapid-onset relief for motion sickness and vertigo, modernizing the $450M global market for the ...
Eli Lilly’s scope in cancer is expanding to radiopharmaceuticals with the $1.4 billion acquisition of Point Biopharma Global, a company in late-stage clinical development with two programs, one of ...
GSK to acquire clinical-stage biopharma company, 35Pharma Inc for $950 million: London, UK Thursday, February 26, 2026, 09:00 Hrs [IST] GSK plc announced that it has entered an ag ...
Therapeutic breakthroughs and innovations driving the next era of personalized medical care BOSTON, MA, UNITED STATES, ...
Just as a disciplined a soccer player might pass on a hopeful shot in favor of a better chance later on, the biopharma ...
As the biopharma industry braces for a second term under President-elect Donald Trump, speculation is swirling around the returning administration’s effect on issues like Medicaid spending, the future ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results